CTI Clinical Trial and Consulting Services (CTI) announces the formation of a new United Kingdom affiliate, CTI Clinical Trial and Consulting Services UK Ltd., and the opening of an office outside of London, England.
“The new company and UK location allows CTI to continue to better serve the growing base of global pharmaceutical and biotechnology companies throughout Western Europe,” states Patrick Earley, General Manager at CTI. “Additionally, the UK pharmaceutical and biotechnology industry is extremely important to medical research as a whole, and UK medical centers perform a great deal of research in the critically ill patient population that CTI excels at, so this is a great opportunity.”
CTI has been working for more than a decade in the drug development industry in North America, Europe, and South America, specializing in clinical research programs involving critically ill patient populations.
About CTI Clinical Trial and Consulting Services
CTI is a specialty drug and market development company offering a full range of services that encompass the entire lifecycle of drug development. These services include regulatory pathway design, clinical trial management, data analysis, medical writing, CME and training program development, market analysis and development and other consulting services. CTI focuses on critically and chronically ill patient populations in the specific disease areas of solid organ transplant, hepatitis, infectious disease, hematology/bone marrow transplant and end-stage organ disease including cardiovascular disease, liver disease and kidney disease. With its combined expertise of clinical knowledge and market experience, CTI is uniquely positioned to incorporate both clinical and market driven endpoints and interpretations to provide results.
CTI is headquartered in Cincinnati, Ohio with locations in North America, Europe, and South America. They were recognized by the Cincinnati Business Courier as a “Best Place to Work” in Greater Cincinnati for 2008 and 2009 and were named a “Top Work Place” by the Cincinnati Enquirer in 2010.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Patient Engagement Platform Checklist
November 22nd 2024Modern clinical trials are more complex than ever, and one significant reason is the increased focus on patient engagement. Incorporating a patient engagement platform into your clinical trial enhances the patient experience and can lead to more successful trials with stronger, more reliable outcomes. We put together this helpful checklist of key features to look out for when choosing a platform for your study.